Dock Street Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Dock Street Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,204	Closed	-$394K	–	36
2015 Q2	$394K	Sell	3,204 -633	-16%	-$75.8K	0.24%	34
2015 Q1	$439K	Hold	3,837	–	–	0.25%	37
2014 Q4	$388K	Buy	3,837 +765	+25%	+$74.3K	0.2%	38
2014 Q3	$280K	Buy	+3,072	New	+$270K	0.17%	47
2014 Q1	–	Sell	-28,992	Closed	-$2.19M	–	65
2013 Q4	$2.19M	Sell	28,992 -26,952	-48%	-$1.91M	1.05%	32
2013 Q3	$3.91M	Buy	55,944 +3,489	+7%	+$229K	2.18%	15
2013 Q2	$3.04M	Buy	+52,455	New	+$3.03M	1.93%	20

Other funds holding IBB

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Dock Street Asset Management's IBB Position: Q3 2015 in Review

Dock Street Asset Management sold out of iShares Biotechnology ETF (IBB) in Q3 2015, closing a stake of 3,204 shares — an estimated $394K sold.

Dock Street Asset Management first reported a position in IBB in Q2 2013 and held it in 7 quarters. The position peaked at $3.91M in Q3 2013. 415 funds tracked by Wall St. Rank hold IBB as of Q3 2015.

Dock Street Asset Management reported no remaining iShares Biotechnology ETF position as of Q3 2015 after selling out during the quarter.
Dock Street Asset Management sold 3,204 iShares Biotechnology ETF shares in Q3 2015, an estimated $394K.
Dock Street Asset Management first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 7 quarters.
Dock Street Asset Management's iShares Biotechnology ETF position peaked at $3.91M in Q3 2013.
415 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2015.

Based on Dock Street Asset Management's 13F filing for Q3 2015, filed 27 Oct 2015.